2025 HCPCS Code G9079
Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t3b-t4, any n; any t, n1 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
TAGS: prostate adenocarcinoma disease demonstration limited evidence predominant diagnosis metastases| Short Description | Onc dx prostate t3b-t4noprog |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | January 01, 2006 |
| HCPCS Action Effective Date | January 01, 2007 |
| HCPCS Pricing Indicator Code | 00 - Service not separately priced by part B (e.G., services not covered, bundled, used by part a only, etc.) |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | 9 - Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99') |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- G9908 - No pt tbco cess interv rng
- G9909 - Doc med rsn no tbco interv
- G9910 - Pt 66+ snp or ltc pos > 90d
- G9911 - Node neg pre/post syst ther
- G9912 - Hbv status assesed and int
- G9913 - No hbv status assesd and int
- G9914 - Pt initiated anti-tnf agent
- G9915 - No documntd hbv results rcd
- G9916 - Funct status past 12 months
- G9917 - Adv dem crgvr limited
- G9918 - No funct stat perf, rsn nos
- G9919 - Scrn nd pos nd prov of rec
- G9920 - Scrning perf and negative
- G9921 - No or part scrn nd rng or os
- G9922 - Sfty cncrns scrn nd mit recs
- G9923 - Safty cncrns scrn and neg
- G9924 - Doc med rsn no scrn or recs
- G9925 - No scrn prov rsn nos
- G9926 - Sfty cncrns scrn but no recs
- G9927 - Doc no warf /fda pt trial